PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tgif1
|
ENSMUSG00000047407.18 | Tgif1 |
Meis3
|
ENSMUSG00000041420.19 | Meis3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Meis3 | mm39_v1_chr7_+_15909010_15909064 | -0.25 | 3.6e-02 | Click! |
Tgif1 | mm39_v1_chr17_-_71158052_71158064 | -0.20 | 8.7e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_22710134 | 12.47 |
ENSMUST00000231328.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chrX_+_10118544 | 11.91 |
ENSMUST00000049910.13
|
Otc
|
ornithine transcarbamylase |
chr16_+_22710027 | 11.42 |
ENSMUST00000231848.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr11_-_5900019 | 10.85 |
ENSMUST00000102920.4
|
Gck
|
glucokinase |
chr15_-_96929086 | 10.47 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr14_+_40827108 | 10.40 |
ENSMUST00000224514.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chrX_+_10118600 | 8.78 |
ENSMUST00000115528.3
|
Otc
|
ornithine transcarbamylase |
chr14_+_40826970 | 8.44 |
ENSMUST00000225720.2
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr19_+_39275518 | 7.22 |
ENSMUST00000003137.15
|
Cyp2c29
|
cytochrome P450, family 2, subfamily c, polypeptide 29 |
chr5_+_65505657 | 6.67 |
ENSMUST00000031096.11
|
Klb
|
klotho beta |
chr7_-_30643444 | 6.29 |
ENSMUST00000062620.9
|
Hamp
|
hepcidin antimicrobial peptide |
chr6_+_41092928 | 6.05 |
ENSMUST00000194399.2
|
Trbv13-1
|
T cell receptor beta, variable 13-1 |
chr7_-_97066937 | 5.85 |
ENSMUST00000043077.8
|
Thrsp
|
thyroid hormone responsive |
chr5_-_87485023 | 5.48 |
ENSMUST00000031195.3
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr15_+_6474808 | 5.45 |
ENSMUST00000022749.17
ENSMUST00000239466.2 |
C9
|
complement component 9 |
chr7_-_30623592 | 5.41 |
ENSMUST00000217812.2
ENSMUST00000074671.9 |
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr15_-_96953823 | 5.31 |
ENSMUST00000023101.10
|
Slc38a4
|
solute carrier family 38, member 4 |
chr8_-_45747883 | 5.28 |
ENSMUST00000026907.6
|
Klkb1
|
kallikrein B, plasma 1 |
chr19_-_39729431 | 5.13 |
ENSMUST00000099472.4
|
Cyp2c68
|
cytochrome P450, family 2, subfamily c, polypeptide 68 |
chr6_+_41092970 | 4.93 |
ENSMUST00000103268.3
|
Trbv13-1
|
T cell receptor beta, variable 13-1 |
chr3_-_116762617 | 4.92 |
ENSMUST00000143611.2
ENSMUST00000040097.14 |
Palmd
|
palmdelphin |
chr9_-_119812042 | 4.86 |
ENSMUST00000214058.2
|
Csrnp1
|
cysteine-serine-rich nuclear protein 1 |
chr7_-_19415301 | 4.83 |
ENSMUST00000150569.9
ENSMUST00000127648.4 ENSMUST00000003071.10 |
Gm44805
Apoc4
|
predicted gene 44805 apolipoprotein C-IV |
chr2_-_160208977 | 4.77 |
ENSMUST00000099126.5
|
Mafb
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
chr14_-_66246652 | 4.72 |
ENSMUST00000059970.9
|
Gulo
|
gulonolactone (L-) oxidase |
chr2_+_71811526 | 4.67 |
ENSMUST00000090826.12
ENSMUST00000102698.10 |
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr12_+_104304631 | 4.59 |
ENSMUST00000043058.5
ENSMUST00000101078.12 |
Serpina3k
Serpina3m
|
serine (or cysteine) peptidase inhibitor, clade A, member 3K serine (or cysteine) peptidase inhibitor, clade A, member 3M |
chr18_+_20798337 | 4.51 |
ENSMUST00000075312.5
|
Ttr
|
transthyretin |
chr3_+_19698631 | 4.46 |
ENSMUST00000029139.9
|
Trim55
|
tripartite motif-containing 55 |
chr3_-_116762476 | 4.44 |
ENSMUST00000119557.8
|
Palmd
|
palmdelphin |
chr2_+_155359868 | 4.44 |
ENSMUST00000029135.15
ENSMUST00000065973.9 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr4_+_102112189 | 4.39 |
ENSMUST00000106908.9
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr10_+_128089965 | 4.35 |
ENSMUST00000060782.5
ENSMUST00000218722.2 |
Apon
|
apolipoprotein N |
chr5_+_137979763 | 4.25 |
ENSMUST00000035390.7
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chr15_+_7120089 | 4.24 |
ENSMUST00000228723.2
|
Lifr
|
LIF receptor alpha |
chr6_+_71350411 | 4.21 |
ENSMUST00000066747.14
|
Cd8a
|
CD8 antigen, alpha chain |
chr4_+_148085179 | 4.16 |
ENSMUST00000103230.5
|
Nppa
|
natriuretic peptide type A |
chr14_-_55204092 | 4.14 |
ENSMUST00000081857.14
|
Myh6
|
myosin, heavy polypeptide 6, cardiac muscle, alpha |
chr14_+_28740162 | 4.13 |
ENSMUST00000055662.4
|
Lrtm1
|
leucine-rich repeats and transmembrane domains 1 |
chr15_-_76906832 | 4.04 |
ENSMUST00000019037.10
ENSMUST00000169226.9 |
Mb
|
myoglobin |
chr8_-_106670014 | 4.00 |
ENSMUST00000038896.8
|
Lcat
|
lecithin cholesterol acyltransferase |
chr9_-_44891626 | 3.97 |
ENSMUST00000002101.12
ENSMUST00000160886.2 |
Cd3g
|
CD3 antigen, gamma polypeptide |
chr10_+_87696339 | 3.96 |
ENSMUST00000121161.8
|
Igf1
|
insulin-like growth factor 1 |
chr9_+_74860335 | 3.92 |
ENSMUST00000170846.8
|
Fam214a
|
family with sequence similarity 214, member A |
chr14_-_55204054 | 3.80 |
ENSMUST00000226297.2
|
Myh6
|
myosin, heavy polypeptide 6, cardiac muscle, alpha |
chr11_+_83637766 | 3.79 |
ENSMUST00000070832.3
|
Wfdc21
|
WAP four-disulfide core domain 21 |
chr6_+_41098273 | 3.79 |
ENSMUST00000103270.4
|
Trbv13-2
|
T cell receptor beta, variable 13-2 |
chr5_-_87074380 | 3.76 |
ENSMUST00000031183.3
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
chr8_+_46944000 | 3.72 |
ENSMUST00000110372.9
ENSMUST00000130563.2 |
Acsl1
|
acyl-CoA synthetase long-chain family member 1 |
chr2_+_155360015 | 3.72 |
ENSMUST00000103142.12
|
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr1_-_172722589 | 3.69 |
ENSMUST00000027824.7
|
Apcs
|
serum amyloid P-component |
chr14_-_55204383 | 3.68 |
ENSMUST00000111456.2
|
Myh6
|
myosin, heavy polypeptide 6, cardiac muscle, alpha |
chr6_-_83654789 | 3.67 |
ENSMUST00000037882.8
|
Cd207
|
CD207 antigen |
chr3_+_146302832 | 3.60 |
ENSMUST00000029837.14
ENSMUST00000147409.2 ENSMUST00000121133.2 |
Uox
|
urate oxidase |
chr2_-_134396268 | 3.60 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr8_+_110717062 | 3.58 |
ENSMUST00000001720.14
ENSMUST00000143741.2 |
Tat
|
tyrosine aminotransferase |
chr5_+_90708962 | 3.54 |
ENSMUST00000094615.8
ENSMUST00000200765.2 |
Albfm1
|
albumin superfamily member 1 |
chr6_+_41118120 | 3.51 |
ENSMUST00000103273.3
|
Trbv15
|
T cell receptor beta, variable 15 |
chr14_-_31362835 | 3.51 |
ENSMUST00000167066.8
ENSMUST00000127204.9 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr17_-_27060539 | 3.48 |
ENSMUST00000015723.5
|
Nkx2-5
|
NK2 homeobox 5 |
chr17_-_32643067 | 3.47 |
ENSMUST00000237130.2
|
Pglyrp2
|
peptidoglycan recognition protein 2 |
chr19_-_39875192 | 3.47 |
ENSMUST00000168838.3
|
Cyp2c69
|
cytochrome P450, family 2, subfamily c, polypeptide 69 |
chr15_-_60793115 | 3.46 |
ENSMUST00000096418.5
|
A1bg
|
alpha-1-B glycoprotein |
chr16_+_26400454 | 3.45 |
ENSMUST00000096129.9
ENSMUST00000166294.9 ENSMUST00000174202.8 ENSMUST00000023156.13 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr7_-_48497771 | 3.45 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr6_+_121323577 | 3.42 |
ENSMUST00000032200.16
|
Slc6a12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
chr2_-_164699462 | 3.38 |
ENSMUST00000109316.8
ENSMUST00000156255.8 ENSMUST00000128110.2 ENSMUST00000109317.10 ENSMUST00000059954.14 |
Pltp
|
phospholipid transfer protein |
chr13_-_4573312 | 3.33 |
ENSMUST00000221564.2
ENSMUST00000078239.5 ENSMUST00000080361.13 |
Akr1c20
|
aldo-keto reductase family 1, member C20 |
chr12_-_103829810 | 3.32 |
ENSMUST00000085056.8
ENSMUST00000072876.12 ENSMUST00000124717.2 |
Serpina1a
|
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
chr2_+_43445333 | 3.32 |
ENSMUST00000028223.9
ENSMUST00000112826.8 |
Kynu
|
kynureninase |
chr9_+_46180362 | 3.30 |
ENSMUST00000214202.2
ENSMUST00000215458.2 ENSMUST00000215187.2 ENSMUST00000213878.2 ENSMUST00000034584.4 |
Apoa5
|
apolipoprotein A-V |
chr1_+_167445815 | 3.27 |
ENSMUST00000111380.2
|
Rxrg
|
retinoid X receptor gamma |
chr7_-_48530777 | 3.22 |
ENSMUST00000058745.15
|
E2f8
|
E2F transcription factor 8 |
chr6_+_129374260 | 3.21 |
ENSMUST00000032262.14
|
Clec1b
|
C-type lectin domain family 1, member b |
chr7_-_98790275 | 3.20 |
ENSMUST00000037968.10
|
Uvrag
|
UV radiation resistance associated gene |
chr15_+_4756684 | 3.19 |
ENSMUST00000161997.8
ENSMUST00000022788.15 |
C6
|
complement component 6 |
chr10_+_87695352 | 3.14 |
ENSMUST00000121952.8
ENSMUST00000126490.8 |
Igf1
|
insulin-like growth factor 1 |
chr10_-_25412010 | 3.12 |
ENSMUST00000179685.3
|
Smlr1
|
small leucine-rich protein 1 |
chr17_-_13159204 | 3.09 |
ENSMUST00000043923.12
|
Acat3
|
acetyl-Coenzyme A acetyltransferase 3 |
chr6_+_116627567 | 3.06 |
ENSMUST00000067354.10
ENSMUST00000178241.4 |
Depp1
|
DEPP1 autophagy regulator |
chr14_-_55204023 | 3.05 |
ENSMUST00000124930.8
|
Myh6
|
myosin, heavy polypeptide 6, cardiac muscle, alpha |
chr17_-_84154196 | 3.03 |
ENSMUST00000234214.2
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr7_-_103477126 | 3.03 |
ENSMUST00000023934.8
|
Hbb-bs
|
hemoglobin, beta adult s chain |
chr17_-_56424577 | 3.02 |
ENSMUST00000019808.12
|
Plin5
|
perilipin 5 |
chr7_-_16549394 | 3.01 |
ENSMUST00000206259.2
|
Fkrp
|
fukutin related protein |
chr2_-_160714473 | 3.00 |
ENSMUST00000103111.9
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr14_-_30645503 | 2.98 |
ENSMUST00000227995.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr7_+_126808016 | 2.98 |
ENSMUST00000206204.2
ENSMUST00000206772.2 |
Mylpf
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr4_-_49549489 | 2.96 |
ENSMUST00000029987.10
|
Aldob
|
aldolase B, fructose-bisphosphate |
chr3_+_94284739 | 2.95 |
ENSMUST00000197040.5
|
Rorc
|
RAR-related orphan receptor gamma |
chr10_+_116137277 | 2.95 |
ENSMUST00000092167.7
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr3_-_82957104 | 2.95 |
ENSMUST00000048246.5
|
Fgb
|
fibrinogen beta chain |
chr14_-_31299275 | 2.95 |
ENSMUST00000112027.9
|
Colq
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
chr2_-_32314017 | 2.94 |
ENSMUST00000113307.9
|
Slc25a25
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
chr15_+_4756657 | 2.94 |
ENSMUST00000162585.8
|
C6
|
complement component 6 |
chr2_-_113883285 | 2.93 |
ENSMUST00000090269.7
|
Actc1
|
actin, alpha, cardiac muscle 1 |
chr5_+_137568113 | 2.90 |
ENSMUST00000031729.13
ENSMUST00000199054.5 |
Tfr2
|
transferrin receptor 2 |
chr9_+_44893077 | 2.87 |
ENSMUST00000034602.9
|
Cd3d
|
CD3 antigen, delta polypeptide |
chrX_+_56257374 | 2.86 |
ENSMUST00000033466.2
|
Cd40lg
|
CD40 ligand |
chr6_+_88701810 | 2.85 |
ENSMUST00000089449.5
|
Mgll
|
monoglyceride lipase |
chr19_-_40062174 | 2.82 |
ENSMUST00000048959.5
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr6_+_41165156 | 2.81 |
ENSMUST00000103277.2
|
Trbv20
|
T cell receptor beta, variable 20 |
chr6_+_41128636 | 2.79 |
ENSMUST00000103274.4
|
Trbv16
|
T cell receptor beta, variable 16 |
chr12_-_103923145 | 2.79 |
ENSMUST00000085054.5
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chrX_+_59044796 | 2.78 |
ENSMUST00000033477.5
|
F9
|
coagulation factor IX |
chr3_+_94284812 | 2.76 |
ENSMUST00000200009.2
|
Rorc
|
RAR-related orphan receptor gamma |
chr6_+_71350519 | 2.76 |
ENSMUST00000172321.3
|
Cd8a
|
CD8 antigen, alpha chain |
chr14_+_14475188 | 2.74 |
ENSMUST00000026315.8
|
Dnase1l3
|
deoxyribonuclease 1-like 3 |
chr8_+_105810380 | 2.74 |
ENSMUST00000093221.13
ENSMUST00000074403.13 |
Ces3b
|
carboxylesterase 3B |
chr4_+_104623505 | 2.71 |
ENSMUST00000031663.10
ENSMUST00000065072.7 |
C8b
|
complement component 8, beta polypeptide |
chr7_+_37882642 | 2.71 |
ENSMUST00000178207.10
ENSMUST00000179525.10 |
1600014C10Rik
|
RIKEN cDNA 1600014C10 gene |
chr10_-_123032821 | 2.70 |
ENSMUST00000219619.2
ENSMUST00000020334.9 |
Usp15
|
ubiquitin specific peptidase 15 |
chr3_+_20039775 | 2.70 |
ENSMUST00000172860.2
|
Cp
|
ceruloplasmin |
chr10_+_87695886 | 2.69 |
ENSMUST00000062862.13
|
Igf1
|
insulin-like growth factor 1 |
chr2_+_43445359 | 2.66 |
ENSMUST00000050511.7
|
Kynu
|
kynureninase |
chr6_+_88701578 | 2.65 |
ENSMUST00000150180.4
ENSMUST00000163271.8 |
Mgll
|
monoglyceride lipase |
chr7_+_119217004 | 2.62 |
ENSMUST00000047929.13
ENSMUST00000135683.3 |
Acsm1
|
acyl-CoA synthetase medium-chain family member 1 |
chr13_-_63036096 | 2.62 |
ENSMUST00000092888.11
|
Fbp1
|
fructose bisphosphatase 1 |
chr2_+_11647610 | 2.60 |
ENSMUST00000028111.6
|
Il2ra
|
interleukin 2 receptor, alpha chain |
chr12_+_104372962 | 2.59 |
ENSMUST00000021506.6
|
Serpina3n
|
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
chr6_+_129374441 | 2.58 |
ENSMUST00000112081.9
ENSMUST00000112079.3 |
Clec1b
|
C-type lectin domain family 1, member b |
chr17_+_24947148 | 2.55 |
ENSMUST00000183214.2
|
Rpl3l
|
ribosomal protein L3-like |
chr9_-_24685572 | 2.51 |
ENSMUST00000052946.12
ENSMUST00000166018.4 |
Tbx20
|
T-box 20 |
chr4_+_98919183 | 2.50 |
ENSMUST00000030280.7
|
Angptl3
|
angiopoietin-like 3 |
chr15_+_82336535 | 2.48 |
ENSMUST00000089129.7
ENSMUST00000229313.2 ENSMUST00000231136.2 |
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr5_+_87148697 | 2.48 |
ENSMUST00000031186.9
|
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr11_-_5865124 | 2.47 |
ENSMUST00000109823.9
ENSMUST00000109822.8 |
Gck
|
glucokinase |
chr11_+_77409392 | 2.46 |
ENSMUST00000147386.2
|
Abhd15
|
abhydrolase domain containing 15 |
chr11_+_77107006 | 2.45 |
ENSMUST00000156488.8
ENSMUST00000037912.12 |
Ssh2
|
slingshot protein phosphatase 2 |
chr2_-_34990689 | 2.44 |
ENSMUST00000226631.2
ENSMUST00000045776.5 ENSMUST00000226972.2 |
AI182371
|
expressed sequence AI182371 |
chr7_+_46401214 | 2.43 |
ENSMUST00000210769.2
ENSMUST00000210272.2 ENSMUST00000075982.4 |
Saa2
|
serum amyloid A 2 |
chr6_+_41107047 | 2.40 |
ENSMUST00000103271.2
|
Trbv13-3
|
T cell receptor beta, variable 13-3 |
chr6_+_41512480 | 2.37 |
ENSMUST00000103289.2
ENSMUST00000103290.2 ENSMUST00000193061.2 |
Trbj1-6
Trbj1-7
|
T cell receptor beta joining 1-6 T cell receptor beta joining 1-7 |
chr2_+_102536701 | 2.37 |
ENSMUST00000123759.8
ENSMUST00000005220.11 ENSMUST00000111212.8 |
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr5_-_87240405 | 2.37 |
ENSMUST00000132667.2
ENSMUST00000145617.8 ENSMUST00000094649.11 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr1_+_67162176 | 2.36 |
ENSMUST00000027144.8
|
Cps1
|
carbamoyl-phosphate synthetase 1 |
chr1_-_121255400 | 2.35 |
ENSMUST00000159085.8
ENSMUST00000159125.2 ENSMUST00000161818.2 |
Insig2
|
insulin induced gene 2 |
chr2_-_84573999 | 2.34 |
ENSMUST00000181711.2
|
Gm19426
|
predicted gene, 19426 |
chr12_-_55033130 | 2.33 |
ENSMUST00000173433.8
ENSMUST00000173803.2 |
Baz1a
Gm20403
|
bromodomain adjacent to zinc finger domain 1A predicted gene 20403 |
chr10_+_93324624 | 2.32 |
ENSMUST00000129421.8
|
Hal
|
histidine ammonia lyase |
chr11_-_120538928 | 2.29 |
ENSMUST00000239158.2
ENSMUST00000026134.3 |
Myadml2
|
myeloid-associated differentiation marker-like 2 |
chr7_-_3298243 | 2.29 |
ENSMUST00000108653.4
|
Nlrp12
|
NLR family, pyrin domain containing 12 |
chr4_-_96552349 | 2.29 |
ENSMUST00000030299.8
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr6_+_122929410 | 2.28 |
ENSMUST00000117173.8
|
Clec4a3
|
C-type lectin domain family 4, member a3 |
chr4_+_109533753 | 2.26 |
ENSMUST00000102724.5
|
Faf1
|
Fas-associated factor 1 |
chr2_+_153334710 | 2.25 |
ENSMUST00000109783.2
|
4930404H24Rik
|
RIKEN cDNA 4930404H24 gene |
chr18_-_39623698 | 2.25 |
ENSMUST00000115567.8
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr2_-_76812799 | 2.24 |
ENSMUST00000011934.13
ENSMUST00000099981.10 ENSMUST00000099980.10 ENSMUST00000111882.9 ENSMUST00000140091.8 |
Ttn
|
titin |
chr13_+_47347301 | 2.23 |
ENSMUST00000110111.4
|
Rnf144b
|
ring finger protein 144B |
chr6_+_41036271 | 2.23 |
ENSMUST00000103265.5
|
Trbv4
|
T cell receptor beta, variable 10 |
chr19_-_46661501 | 2.23 |
ENSMUST00000236174.2
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr7_+_114344920 | 2.23 |
ENSMUST00000136645.8
ENSMUST00000169913.8 |
Insc
|
INSC spindle orientation adaptor protein |
chr14_-_33996185 | 2.21 |
ENSMUST00000227006.2
|
Shld2
|
shieldin complex subunit 2 |
chr10_+_36383008 | 2.21 |
ENSMUST00000168572.8
|
Hs3st5
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
chrX_-_100311824 | 2.19 |
ENSMUST00000033664.14
|
Il2rg
|
interleukin 2 receptor, gamma chain |
chr9_-_110745929 | 2.17 |
ENSMUST00000177678.2
|
Fam240a
|
family with sequence similarity 240 member A |
chr1_+_88334678 | 2.17 |
ENSMUST00000027518.12
|
Spp2
|
secreted phosphoprotein 2 |
chr1_+_61017057 | 2.15 |
ENSMUST00000027162.12
ENSMUST00000102827.4 |
Icos
|
inducible T cell co-stimulator |
chr2_+_71884943 | 2.15 |
ENSMUST00000028525.6
|
Rapgef4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr8_+_35842872 | 2.14 |
ENSMUST00000210337.2
ENSMUST00000070481.8 ENSMUST00000211648.2 |
Ppp1r3b
|
protein phosphatase 1, regulatory subunit 3B |
chr1_-_180023518 | 2.14 |
ENSMUST00000162769.8
ENSMUST00000161379.2 ENSMUST00000027766.13 ENSMUST00000161814.8 |
Coq8a
|
coenzyme Q8A |
chr17_-_84154173 | 2.13 |
ENSMUST00000000687.9
|
Haao
|
3-hydroxyanthranilate 3,4-dioxygenase |
chr14_+_53088747 | 2.11 |
ENSMUST00000103588.4
|
Trav13d-1
|
T cell receptor alpha variable 13D-1 |
chr15_+_9279915 | 2.10 |
ENSMUST00000022861.9
|
Ugt3a1
|
UDP glycosyltransferases 3 family, polypeptide A1 |
chr1_+_139429430 | 2.10 |
ENSMUST00000027615.7
|
F13b
|
coagulation factor XIII, beta subunit |
chr15_-_96947963 | 2.09 |
ENSMUST00000230907.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr13_+_81034214 | 2.08 |
ENSMUST00000161441.2
|
Arrdc3
|
arrestin domain containing 3 |
chr13_+_25127127 | 2.07 |
ENSMUST00000021773.13
|
Gpld1
|
glycosylphosphatidylinositol specific phospholipase D1 |
chr11_-_63813083 | 2.07 |
ENSMUST00000094103.4
|
Hs3st3b1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
chr7_-_126303689 | 2.07 |
ENSMUST00000135087.8
|
Coro1a
|
coronin, actin binding protein 1A |
chr1_+_171041583 | 2.07 |
ENSMUST00000111328.8
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3 |
chr19_-_46661321 | 2.07 |
ENSMUST00000026012.8
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr8_+_129085719 | 2.06 |
ENSMUST00000026917.10
|
Nrp1
|
neuropilin 1 |
chr6_-_135145129 | 2.05 |
ENSMUST00000045855.9
|
Hebp1
|
heme binding protein 1 |
chr15_-_57939821 | 2.05 |
ENSMUST00000176935.8
ENSMUST00000070143.13 ENSMUST00000110168.8 |
Gm29394
Zhx1
|
predicted gene 29394 zinc fingers and homeoboxes 1 |
chr1_-_54965470 | 2.04 |
ENSMUST00000179030.8
ENSMUST00000044359.16 |
Ankrd44
|
ankyrin repeat domain 44 |
chr1_-_121255448 | 2.04 |
ENSMUST00000186915.2
ENSMUST00000160968.8 ENSMUST00000162582.2 |
Insig2
|
insulin induced gene 2 |
chr5_-_87288177 | 2.03 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr2_+_58645189 | 2.02 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr10_+_87695117 | 2.02 |
ENSMUST00000105300.9
|
Igf1
|
insulin-like growth factor 1 |
chr1_-_192880260 | 2.02 |
ENSMUST00000161367.2
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr1_+_87254729 | 2.01 |
ENSMUST00000172794.8
ENSMUST00000164992.9 ENSMUST00000173173.8 |
Gigyf2
|
GRB10 interacting GYF protein 2 |
chr6_-_71239216 | 2.01 |
ENSMUST00000129630.3
ENSMUST00000114186.9 ENSMUST00000074301.10 |
Smyd1
|
SET and MYND domain containing 1 |
chr2_-_25390625 | 2.01 |
ENSMUST00000040042.11
|
C8g
|
complement component 8, gamma polypeptide |
chr17_+_25023263 | 2.00 |
ENSMUST00000234372.2
ENSMUST00000024972.7 |
Meiob
|
meiosis specific with OB domains |
chr12_-_55033113 | 1.99 |
ENSMUST00000038926.13
|
Baz1a
|
bromodomain adjacent to zinc finger domain 1A |
chr19_-_4109446 | 1.97 |
ENSMUST00000189808.7
|
Gstp3
|
glutathione S-transferase pi 3 |
chr11_+_117672902 | 1.96 |
ENSMUST00000127080.9
|
Tmc8
|
transmembrane channel-like gene family 8 |
chr8_-_72966840 | 1.96 |
ENSMUST00000238973.2
|
Cib3
|
calcium and integrin binding family member 3 |
chr5_-_87402659 | 1.95 |
ENSMUST00000075858.4
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr10_+_21253190 | 1.94 |
ENSMUST00000042699.14
|
Aldh8a1
|
aldehyde dehydrogenase 8 family, member A1 |
chr1_-_180023467 | 1.94 |
ENSMUST00000161746.2
ENSMUST00000160879.7 |
Coq8a
|
coenzyme Q8A |
chr8_-_41668182 | 1.93 |
ENSMUST00000034003.5
|
Fgl1
|
fibrinogen-like protein 1 |
chr7_-_140590605 | 1.93 |
ENSMUST00000026565.7
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr16_+_22739191 | 1.92 |
ENSMUST00000116625.10
|
Fetub
|
fetuin beta |
chr12_+_56742413 | 1.92 |
ENSMUST00000001538.10
|
Pax9
|
paired box 9 |
chr14_+_52875909 | 1.91 |
ENSMUST00000103571.2
|
Trav6-1
|
T cell receptor alpha variable 6-1 |
chr10_-_93375832 | 1.91 |
ENSMUST00000016034.3
|
Amdhd1
|
amidohydrolase domain containing 1 |
chr7_-_114162125 | 1.90 |
ENSMUST00000211506.2
ENSMUST00000119712.8 ENSMUST00000032908.15 |
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1 |
chr6_+_41039255 | 1.89 |
ENSMUST00000103266.3
|
Trbv5
|
T cell receptor beta, variable 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 20.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
6.3 | 18.8 | GO:0009087 | methionine catabolic process(GO:0009087) |
3.7 | 14.7 | GO:0007522 | visceral muscle development(GO:0007522) |
2.9 | 11.7 | GO:0034760 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
2.9 | 14.4 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
2.7 | 8.2 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
2.0 | 6.0 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
1.9 | 13.2 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.7 | 5.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.7 | 10.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.5 | 6.1 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.5 | 4.5 | GO:0071939 | vitamin A transport(GO:0071938) vitamin A import(GO:0071939) |
1.2 | 3.7 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.2 | 9.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.2 | 1.2 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
1.2 | 3.5 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
1.1 | 3.4 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
1.1 | 3.2 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.1 | 5.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.0 | 4.2 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
1.0 | 7.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.0 | 6.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.0 | 1.0 | GO:0002458 | peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) |
1.0 | 7.8 | GO:0032796 | uropod organization(GO:0032796) |
1.0 | 2.9 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.9 | 4.6 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.9 | 4.6 | GO:0043056 | forward locomotion(GO:0043056) |
0.9 | 6.4 | GO:0015862 | uridine transport(GO:0015862) |
0.9 | 2.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.9 | 2.7 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.9 | 4.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.9 | 0.9 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.8 | 4.2 | GO:0006548 | histidine catabolic process(GO:0006548) |
0.8 | 2.5 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 6.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.8 | 3.3 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.8 | 3.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.8 | 4.7 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.8 | 7.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.8 | 0.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.8 | 3.1 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.8 | 2.3 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.7 | 3.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.7 | 2.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.7 | 2.2 | GO:0036145 | dendritic cell homeostasis(GO:0036145) |
0.7 | 2.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.7 | 4.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 2.1 | GO:0071846 | actin filament debranching(GO:0071846) |
0.7 | 4.2 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.7 | 2.1 | GO:0097374 | cell migration involved in vasculogenesis(GO:0035441) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) sensory neuron axon guidance(GO:0097374) |
0.7 | 23.9 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.7 | 3.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.7 | 0.7 | GO:1901295 | regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
0.7 | 2.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.6 | 4.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.6 | 3.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.6 | 1.9 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.6 | 2.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 7.0 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.6 | 4.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.6 | 1.9 | GO:0006212 | uracil catabolic process(GO:0006212) uracil metabolic process(GO:0019860) |
0.6 | 4.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 3.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.6 | 3.0 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.6 | 4.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 2.9 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.6 | 1.8 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.6 | 1.8 | GO:0002632 | regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.6 | 1.8 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.6 | 1.7 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.6 | 1.7 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
0.6 | 1.7 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.6 | 1.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.6 | 4.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 4.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.6 | 2.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.6 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.6 | 5.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.6 | 2.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.6 | 5.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 4.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.5 | 3.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.5 | 6.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 7.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.5 | 1.6 | GO:0002584 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.5 | 3.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 2.1 | GO:0006507 | GPI anchor release(GO:0006507) |
0.5 | 16.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 5.5 | GO:1903797 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.5 | 1.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.5 | 3.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 7.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 3.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.5 | 2.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 2.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.4 | 1.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 3.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.4 | 0.9 | GO:0042977 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
0.4 | 3.0 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 1.3 | GO:0014728 | regulation of the force of skeletal muscle contraction(GO:0014728) regulation of skeletal muscle contraction by chemo-mechanical energy conversion(GO:0014862) |
0.4 | 3.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.4 | 1.2 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) |
0.4 | 3.7 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 2.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.4 | 3.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 1.2 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.4 | 1.5 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.4 | 0.8 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 5.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 1.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.4 | 1.1 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.4 | 1.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.4 | 1.1 | GO:0036275 | response to 5-fluorouracil(GO:0036275) |
0.4 | 1.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 1.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.4 | 2.2 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.4 | 5.1 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.4 | 1.1 | GO:0019405 | hexitol metabolic process(GO:0006059) alditol catabolic process(GO:0019405) |
0.4 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 3.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.3 | 3.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 1.0 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 1.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.0 | GO:0043366 | beta selection(GO:0043366) |
0.3 | 8.2 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.3 | 1.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.3 | 3.2 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 1.3 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.3 | 0.9 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.3 | 0.6 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.3 | 1.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 2.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.3 | 2.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 1.2 | GO:0000105 | histidine biosynthetic process(GO:0000105) 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.3 | 3.6 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 0.6 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.3 | 1.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 1.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.3 | 2.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.3 | 2.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.3 | 0.8 | GO:0070256 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.3 | 6.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 1.4 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.3 | 0.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.3 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 5.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 1.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 0.8 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.3 | 2.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.3 | 0.8 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.3 | 4.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 1.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.3 | 1.3 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.3 | 0.8 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.3 | 0.8 | GO:0042128 | nitrate assimilation(GO:0042128) |
0.3 | 1.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.3 | 14.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 1.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.3 | 2.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.3 | 1.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 0.7 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) response to diterpene(GO:1904629) cellular response to diterpene(GO:1904630) response to glucoside(GO:1904631) cellular response to glucoside(GO:1904632) |
0.2 | 0.5 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.7 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.5 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.2 | 4.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 0.2 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 0.7 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.2 | 1.7 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.2 | 0.5 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 1.7 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 0.7 | GO:0061723 | glycophagy(GO:0061723) |
0.2 | 1.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 0.9 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.2 | 1.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 2.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.2 | 1.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.7 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.2 | 2.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 1.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 1.8 | GO:0019659 | glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.2 | 3.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 6.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.9 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.2 | 2.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.6 | GO:0018003 | peptidyl-lysine N6-acetylation(GO:0018003) |
0.2 | 4.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 0.4 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.2 | 2.1 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.6 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 1.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 1.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.2 | 1.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.2 | 7.5 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 1.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.6 | GO:1903699 | tarsal gland development(GO:1903699) |
0.2 | 1.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.6 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.2 | 1.8 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 2.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 0.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 3.3 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.6 | GO:0030887 | positive regulation of myeloid dendritic cell activation(GO:0030887) |
0.2 | 0.2 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.2 | 0.8 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 4.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.2 | 1.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 3.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.2 | 0.9 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 0.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 2.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 0.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.2 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.2 | 0.5 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.2 | 0.7 | GO:0003322 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.2 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.2 | 0.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 1.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.7 | GO:0010286 | heat acclimation(GO:0010286) |
0.2 | 0.7 | GO:0035483 | gastric emptying(GO:0035483) |
0.2 | 0.5 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 2.0 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.1 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 1.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.6 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.2 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.8 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 3.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 5.9 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.9 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 2.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.2 | 0.8 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 1.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 1.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.5 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.2 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 2.3 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 0.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 2.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 1.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.6 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 0.4 | GO:0046061 | DNA protection(GO:0042262) dATP catabolic process(GO:0046061) |
0.1 | 1.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.6 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.4 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.1 | 1.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 5.3 | GO:0050779 | RNA destabilization(GO:0050779) |
0.1 | 2.7 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.4 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
0.1 | 1.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 1.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0035037 | sperm entry(GO:0035037) |
0.1 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 2.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 1.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.5 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 1.7 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 5.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.2 | GO:0072641 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.9 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.5 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 1.2 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.5 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 3.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 1.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.9 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 1.7 | GO:0044144 | modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 1.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 2.5 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 1.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.7 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.5 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.1 | 0.4 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.4 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.1 | 2.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 2.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 1.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 2.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.2 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.1 | 0.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 5.9 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.1 | 0.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 2.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.1 | 0.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 15.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 1.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 4.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 1.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 1.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 2.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.5 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 2.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.2 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 4.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 6.7 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.3 | GO:0006583 | melanin biosynthetic process from tyrosine(GO:0006583) |
0.1 | 1.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 1.0 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 1.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:0045212 | neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 0.1 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 | 0.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 3.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.4 | GO:2000292 | negative regulation of eating behavior(GO:1903999) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.1 | 1.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.6 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 0.1 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 1.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 2.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.3 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) DNA replication preinitiation complex assembly(GO:0071163) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.1 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 2.4 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.6 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 2.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.1 | 0.4 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.1 | 1.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 1.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 18.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.3 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination(GO:1905168) |
0.1 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.4 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.1 | 1.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.3 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.1 | 2.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.3 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.1 | 0.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 1.5 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.7 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.2 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.1 | 2.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.7 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.2 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.1 | 0.3 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.3 | GO:0061188 | histone H4-K20 demethylation(GO:0035574) regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.3 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.2 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.9 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.7 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.5 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.3 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.2 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.1 | 5.8 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 1.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 1.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 1.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.3 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.3 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.6 | GO:0033292 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.1 | 0.2 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.8 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.4 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 2.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 1.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 2.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.3 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 0.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.3 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 1.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 2.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 1.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.6 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 0.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 2.7 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.1 | 0.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 4.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 1.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 2.0 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 1.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.2 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.1 | 2.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 1.8 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.3 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.1 | 0.6 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.0 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 1.3 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 4.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 1.0 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.7 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.4 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 1.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.2 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.3 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.4 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 1.4 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.2 | GO:0033373 | mast cell secretory granule organization(GO:0033364) protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.0 | 1.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.5 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.3 | GO:0060324 | face development(GO:0060324) |
0.0 | 1.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.2 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.0 | 0.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 0.1 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.0 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.2 | GO:0050823 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.0 | 1.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.5 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.3 | GO:0060158 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.3 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.9 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.0 | 0.1 | GO:0007225 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
0.0 | 0.1 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.9 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.7 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.0 | 0.2 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.0 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 1.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 1.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.2 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.0 | 0.1 | GO:0018364 | box C/D snoRNA 3'-end processing(GO:0000494) peptidyl-glutamine methylation(GO:0018364) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.1 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.0 | 0.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 1.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.8 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 1.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.1 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.1 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.0 | 0.6 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 1.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.3 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.2 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 1.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 2.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.1 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.3 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.0 | 0.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.8 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.6 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.3 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.0 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.3 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.0 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.0 | 0.0 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.0 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 16.3 | GO:0005579 | membrane attack complex(GO:0005579) |
1.3 | 13.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 5.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.1 | 4.3 | GO:0008623 | CHRAC(GO:0008623) |
1.0 | 4.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
1.0 | 2.9 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
1.0 | 4.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 11.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 22.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.7 | 12.5 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.0 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.6 | 4.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 3.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 1.5 | GO:0097632 | extrinsic component of pre-autophagosomal structure membrane(GO:0097632) |
0.5 | 2.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.5 | 1.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 19.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 2.2 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.4 | 4.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 3.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 11.6 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 3.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 2.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 1.6 | GO:0005638 | lamin filament(GO:0005638) |
0.4 | 1.1 | GO:0097132 | cyclin D2-CDK6 complex(GO:0097132) |
0.4 | 4.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 1.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 1.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.4 | 1.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.4 | 1.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.3 | 2.8 | GO:0033503 | HULC complex(GO:0033503) |
0.3 | 0.9 | GO:0036398 | TCR signalosome(GO:0036398) |
0.3 | 9.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 3.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 1.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.3 | 2.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 60.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 3.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.2 | GO:0035841 | new growing cell tip(GO:0035841) |
0.2 | 2.7 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.7 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.2 | 2.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 2.9 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.7 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) cyclin K-CDK13 complex(GO:0002945) |
0.2 | 0.9 | GO:0097447 | dendritic tree(GO:0097447) |
0.2 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 2.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 6.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 0.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.2 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 2.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 2.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.7 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.2 | 2.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 2.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 2.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 4.9 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 1.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 2.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 3.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.8 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.1 | 3.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 7.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 2.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.1 | 0.6 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.1 | 1.4 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.1 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 1.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 1.2 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.1 | 1.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 14.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 5.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.3 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.1 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.1 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 3.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 19.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 4.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 1.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 36.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 2.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 1.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.4 | GO:0070449 | elongin complex(GO:0070449) |
0.1 | 0.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0060473 | cortical granule(GO:0060473) |
0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.4 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 1.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 1.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.0 | GO:0005657 | replication fork(GO:0005657) |
0.0 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 3.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 8.8 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.0 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.7 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.5 | GO:0005858 | axonemal dynein complex(GO:0005858) inner dynein arm(GO:0036156) |
0.0 | 2.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 1.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 1.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 1.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 2.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 3.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 1.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 10.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 1.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.0 | 0.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 3.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 4.7 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.1 | GO:0098890 | extrinsic component of postsynaptic membrane(GO:0098890) |
0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.8 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 3.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.0 | GO:0043291 | RAVE complex(GO:0043291) |
0.0 | 0.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 6.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.0 | 15.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 20.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
4.7 | 18.8 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
4.0 | 23.9 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
2.4 | 2.4 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
2.1 | 14.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.1 | 8.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.6 | 8.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.6 | 9.3 | GO:0008142 | oxysterol binding(GO:0008142) |
1.5 | 6.0 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.4 | 5.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.3 | 13.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.2 | 3.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.2 | 3.6 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.1 | 3.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.1 | 2.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.1 | 4.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
1.0 | 4.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
1.0 | 2.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.9 | 4.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.9 | 3.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.9 | 11.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 4.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.8 | 5.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.8 | 3.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.8 | 3.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.8 | 5.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.8 | 2.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.7 | 3.7 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.7 | 4.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.7 | 2.8 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.7 | 4.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.7 | 4.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.7 | 4.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 4.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 2.0 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.6 | 3.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 25.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.6 | 1.9 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
0.6 | 3.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.6 | 1.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.6 | 2.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.6 | 1.7 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.6 | 2.3 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.6 | 4.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 1.7 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.6 | 3.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.6 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.5 | 8.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 2.1 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.5 | 1.5 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.5 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 3.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.5 | 3.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 2.2 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.4 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 2.1 | GO:2001070 | starch binding(GO:2001070) |
0.4 | 1.3 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.4 | 2.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.4 | 1.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.4 | 0.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 8.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 1.2 | GO:0016824 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.4 | 1.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 2.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 1.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.1 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.4 | 3.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 3.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.4 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.4 | 1.1 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
0.4 | 1.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 1.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 2.1 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 4.3 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 2.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.3 | 3.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 2.6 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 0.6 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 1.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 4.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.3 | 1.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 1.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 2.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 8.6 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.3 | 1.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.3 | 1.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 0.9 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.3 | 4.7 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.3 | 0.9 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
0.3 | 13.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 6.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 0.9 | GO:0070540 | stearic acid binding(GO:0070540) |
0.3 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.3 | 4.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 0.8 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.3 | 4.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 0.8 | GO:0008127 | quercetin 2,3-dioxygenase activity(GO:0008127) |
0.3 | 1.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 12.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 1.8 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.3 | 7.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.3 | 1.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 1.5 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.3 | 1.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 1.2 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 1.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 1.9 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 5.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.7 | GO:0004134 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
0.2 | 2.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.2 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 1.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 2.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 2.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.1 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
0.2 | 4.1 | GO:0070330 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.2 | 2.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 3.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 1.0 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.2 | 1.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 6.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 3.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.6 | GO:0032394 | MHC class Ib receptor activity(GO:0032394) |
0.2 | 1.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 1.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 3.7 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.7 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 0.5 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.2 | 1.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.7 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.2 | 1.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 1.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 2.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 1.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 7.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 3.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 1.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.5 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.4 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.1 | 0.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 3.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 0.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.8 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.1 | 1.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 1.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 11.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.4 | GO:0008119 | thiopurine S-methyltransferase activity(GO:0008119) |
0.1 | 0.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.7 | GO:0070404 | NADH binding(GO:0070404) |
0.1 | 0.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 1.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.4 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 3.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.7 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 1.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.7 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.1 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 6.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 6.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.1 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 3.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 0.4 | GO:0055105 | ubiquitin-protein transferase inhibitor activity(GO:0055105) |
0.1 | 1.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 2.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.4 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 1.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 17.0 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 2.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.6 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 8.5 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 0.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.3 | GO:0004493 | methylmalonyl-CoA epimerase activity(GO:0004493) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.1 | 3.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.1 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.2 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.1 | 10.7 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 6.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.3 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 1.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 4.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.7 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.9 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.1 | 0.4 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 2.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 2.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 5.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0070002 | glutamic-type peptidase activity(GO:0070002) |
0.1 | 0.6 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 1.1 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 2.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 1.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 2.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 5.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.2 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 13.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 1.1 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 7.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.7 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 2.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 1.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.4 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 1.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.2 | GO:0032093 | SAM domain binding(GO:0032093) |
0.0 | 1.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 1.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 1.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.0 | 1.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 1.7 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 1.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 1.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 2.2 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 1.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.0 | 6.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.7 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0043125 | epidermal growth factor-activated receptor activity(GO:0005006) ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.6 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 3.3 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 1.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.7 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.0 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.0 | 0.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0008158 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 1.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 1.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 1.7 | GO:0001047 | core promoter binding(GO:0001047) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 31.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 21.7 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 28.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 9.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 7.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 8.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 9.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 5.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 5.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 6.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 3.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 7.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 2.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.7 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 2.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 5.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 2.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 2.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 2.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 2.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.9 | 10.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 9.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 11.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 19.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.5 | 16.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 14.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 5.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 9.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 7.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 12.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 4.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 1.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 19.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 8.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 6.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 19.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 4.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.3 | 3.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 9.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 4.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 6.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 4.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 6.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.2 | 11.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 2.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 6.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 37.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 2.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 3.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 3.5 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 4.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 3.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 5.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 3.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 6.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 5.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 5.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 1.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 4.9 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 4.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.5 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 4.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 3.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 5.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 14.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 2.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 1.1 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.4 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 2.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 4.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 1.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 3.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 2.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 2.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 1.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 1.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 2.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.9 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |